| Mucinex DM Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Mucinex DM 30 mg-600 mg | tablet, extended release | oral | 1.0 each | OTC |
| Mucinex DM 30 mg-600 mg | tablet, extended release | oral | 1.0 each | OTC |
Posted by red471 2 months ago
It seemed to calm the coughing and thin the mucous, but I actually had a better experience with the nock off from Walgreens, ...
Posted by bobbyjones1987 6 months ago
took 2 pills and the next morning woke up and felt a little sick once i got to work i had severe nausea vomiting and loss of ...
Posted by angry about 1 year ago
After taking one pill and nothing else I suffered 5 seizures, vomiting and temporary loss of bladder control. My advice is no...
RECKITT BENCKISER GROUP PLC - Acquisition Of Adams Respiratory ... - Trading Markets (press release)
Mucinex is also available in other dosage forms, including; Mucinex DM which combines the long-acting expectorant properties of guaifenesin with the cough ...
Mon Dec 10 08:25:27 -0500 2007
adams expects high end of 2008 outlook - Forbes
... the products are similar to adams' mucinex and mucinex dm cough medications. the enforcement by the fda is expected to improve adams' sales position, ...
Mon Oct 29 14:15:06 -0400 2007
adams respiratory shares rise on outlook - Forbes
"management had initially assumed only $15 million of additional sales from the removal of competing products for mucinex d and dm, but based on product ...
Mon Oct 29 20:55:42 -0400 2007
dextromethorphan - The hydrobromide salt form of dextromethorphan, a synthetic, methylated dextrorotary analogue of levorphanol, a substance related to codeine and a non-opioid derivate of morphine. Dextromethorphan exhibits antitussive activity and is devoid of analgesic or addictive property. This agent crosses the blood-brain-barrier and activates sigma opioid receptors on the cough center in the central nervous system, thereby suppressing the cough reflex.
guaifenesin - A glyceryl guaiacolate with expectorant effects. Guaifenesin increases respiratory tract mucus secretions, acts as an irritant to gastric vagal receptors and recruits efferent parasympathetic reflexes that cause glandular exocytosis. This agent reduces the viscosity of mucus secretion by reducing adhesiveness and surface tension as well as increasing hydration of mucus. Guaifenesin promotes the efficiency of the mucociliary mechanism important in removing accumulated secretions from the upper and lower airway.